Рет қаралды 5,138
Earn CME for related activities: www.naccme.com/oln
Featuring a presentation by Dr. Christopher A. Fausel, this on-demand webcast examines novel chemotherapeutic formulations and targeted agents in the treatment of AML in terms of clinical outcomes, pharmacologic profiles, reduced toxicity, and pharmacoeconomic data.
© 2018 NACCME, an HMP Company